dalteparin has been researched along with Coagulation Disorders, Blood in 26 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " No adverse maternal-fetal side effects were reported on enoxaparin alone or enoxaparin-metformin." | 6.74 | Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss. ( Glueck, CJ; Goldenberg, N; Khan, N; Ramidi, G; Wang, P, 2009) |
| "SARS-CoV-2 patients with acute respiratory distress syndrome show elevated fibrinogen activity, high D-dimer levels and maximum amplitude of clot strength." | 3.96 | Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study. ( Antonelli, M; Biasucci, DG; Bocci, MG; Carelli, S; Consalvo, LM; Cutuli, SL; De Candia, E; Franceschi, F; Gori, C; Grieco, DL; Maviglia, R; Mercurio, G; Montini, L; Nardi, G; Natalini, D; Pisapia, L; Rosenkranz, R, 2020) |
| " No adverse maternal-fetal side effects were reported on enoxaparin alone or enoxaparin-metformin." | 2.74 | Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss. ( Glueck, CJ; Goldenberg, N; Khan, N; Ramidi, G; Wang, P, 2009) |
| "Changes in the hemostasis system in choledocholithiasis, taking into account the obturation jaundice severity and possibility of the correction conduction, using miniinvasive operative interventions, were studied." | 1.40 | [Changes of the hemostasis system in patients with obturation jaundice caused by choledocholithiasis, and possibilities of their correction with the help of miniinvasive operative interventions]. ( Tkachenko, AI, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 5 (19.23) | 2.80 |
| Authors | Studies |
|---|---|
| Faĭl', IL | 1 |
| Dolgikh, VT | 1 |
| Morova, NA | 1 |
| Kireeva, NV | 1 |
| Smirnov, DE | 1 |
| Kovaleva, SV | 1 |
| Myasnikova, VV | 1 |
| Galenko-Yaroshevskii, PA | 1 |
| Lysenkov, SP | 1 |
| Gigineishvili, MA | 1 |
| Berberashvili, TM | 1 |
| Goldsmith, DJ | 1 |
| Suri, C | 1 |
| Liptay, L | 1 |
| Gáspár, L | 1 |
| Tkachenko, AI | 1 |
| De Lorenzo, F | 1 |
| Newberry, D | 1 |
| Scully, M | 1 |
| Kadziola, Z | 1 |
| Dawson, G | 1 |
| Ranlall, N | 1 |
| Saba, N | 1 |
| Noorani, A | 1 |
| Kashani, S | 1 |
| Williams, R | 1 |
| Kakkar, VV | 1 |
| Lazar, M | 1 |
| Tomey, MI | 1 |
| Ghia, S | 1 |
| Katz, D | 1 |
| Derr, K | 1 |
| Narula, J | 1 |
| Bhatt, HV | 1 |
| Serrano, F | 1 |
| Bisdorff-Bresson, A | 1 |
| Sroussi, J | 1 |
| Aymard, A | 1 |
| Wassef, M | 1 |
| Civelli, V | 1 |
| Boujlel, S | 1 |
| Houdart, E | 1 |
| Drouet, L | 1 |
| Bocci, MG | 1 |
| Maviglia, R | 1 |
| Consalvo, LM | 1 |
| Grieco, DL | 1 |
| Montini, L | 1 |
| Mercurio, G | 1 |
| Nardi, G | 1 |
| Pisapia, L | 1 |
| Cutuli, SL | 1 |
| Biasucci, DG | 1 |
| Gori, C | 1 |
| Rosenkranz, R | 1 |
| De Candia, E | 1 |
| Carelli, S | 1 |
| Natalini, D | 1 |
| Antonelli, M | 1 |
| Franceschi, F | 1 |
| Rahbar, E | 1 |
| Cotton, BA | 1 |
| Wade, CE | 1 |
| Cardenas, JC | 1 |
| Ladha, A | 1 |
| Alam, A | 1 |
| Idestrup, C | 1 |
| Sawyer, J | 1 |
| Choi, S | 1 |
| Glueck, CJ | 5 |
| Freiberg, RA | 3 |
| Wang, P | 5 |
| Dang, JD | 1 |
| Davis, LE | 1 |
| Ansell, JE | 1 |
| Stamenkovic, DM | 1 |
| Jankovic, ZB | 1 |
| Toogood, GJ | 1 |
| Lodge, JP | 1 |
| Bellamy, MC | 1 |
| Ramidi, G | 1 |
| Khan, N | 1 |
| Goldenberg, N | 2 |
| Altman, R | 1 |
| Scazziota, AS | 1 |
| Pons, S | 1 |
| Herrera, L | 1 |
| Keller, AG | 1 |
| Assefi, AR | 1 |
| Di Girolamo, G | 1 |
| Mishalov, VG | 1 |
| Terekhov, SN | 1 |
| Zaria, IL | 1 |
| Sukhoviĭ, MV | 1 |
| Semeniaka, VI | 1 |
| Aver'ianov, EV | 1 |
| Burnaeva, SV | 1 |
| Klingel, R | 1 |
| Schaefer, M | 1 |
| Schwarting, A | 1 |
| Himmelsbach, F | 1 |
| Altes, U | 1 |
| Uhlenbusch-Körwer, I | 1 |
| Hafner, G | 1 |
| Sieve, L | 2 |
| Stine, KC | 1 |
| Saylors, RL | 1 |
| Saccente, CS | 1 |
| Becton, DL | 1 |
| Finkelstein, Y | 1 |
| Aloni, D | 1 |
| Kimia, A | 1 |
| Sommer, R | 1 |
| Sirota, L | 1 |
| Fontaine, RN | 1 |
| Tracy, T | 1 |
| Dorsch, O | 1 |
| Krieter, DH | 1 |
| Lemke, HD | 1 |
| Fischer, S | 1 |
| Melzer, N | 1 |
| Sieder, C | 1 |
| Bramlage, P | 1 |
| Harenberg, J | 1 |
| Stattin, K | 1 |
| Lipcsey, M | 1 |
| Andersson, H | 1 |
| Pontén, E | 1 |
| Bülow Anderberg, S | 1 |
| Gradin, A | 1 |
| Larsson, A | 1 |
| Lubenow, N | 1 |
| von Seth, M | 1 |
| Rubertsson, S | 1 |
| Hultström, M | 1 |
| Frithiof, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analgesic and Hemodynamic Effects of Continuous Epidural Analgesia Compared to Paravertebral Block in Liver Resection Patients[NCT02909322] | Phase 4 | 50 participants (Anticipated) | Interventional | 2016-04-30 | Recruiting | ||
| A Multi-center, Prospective, Open-label, 8-weeks Study to Investigate the Efficacy, Safety and Pharmacokinetics of Certoparin (3000 IU Anti-Xa Bolus, With the Option to Titrate Dose)in the Prophylaxis of Clotting in the Extracorporeal Circuit in Patients [NCT01179620] | Phase 3 | 109 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19[NCT04316884] | 300 participants (Anticipated) | Observational | 2020-03-12 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dalteparin and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic A | 2016 |
7 trials available for dalteparin and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Low molecular weight heparin (bemiparin sodium) and the coagulation profile of patients with heart failure.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Disorders; Double-Blind Method; Factor VII; F | 2002 |
Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
Topics: Antithrombins; Blood Coagulation Disorders; Enoxaparin; Humans; Risk Factors; Venous Thromboembolism | 2021 |
Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Blood Coagulation Disorders; Dose- | 2009 |
Effects of enoxaparin preparations on thrombin generation and their correlation with their anti-FXa activity.
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Cross-Over Studies; Dose-Response Relationship, | 2011 |
Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Blood Coagulation Disorders; Case-Control Studies; | 2004 |
Hypofibrinolysis, thrombophilia, osteonecrosis.
Topics: Adult; Analysis of Variance; Blood Coagulation Disorders; Child; Drug Administration Schedule; Enoxa | 2001 |
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Disorders; Female; Hemorrhage; Hep | 2012 |
18 other studies available for dalteparin and Coagulation Disorders, Blood
| Article | Year |
|---|---|
[Changes in coagulation hemostasis in patients after coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Blood Coagulation Disorders; Coronary Artery Bypass; Fibrin Fibrinogen Degr | 2008 |
Pharmacological correction of hemostasis-regulating function of the lungs in rats with uncomplicated pregnancy and experimental gestosis.
Topics: Animals; Anticoagulants; Birth Weight; Blood Coagulation; Blood Coagulation Disorders; Female; Fetal | 2005 |
Calciphylaxis, thrombotic diathesis and defects in coagulation regulation.
Topics: Blood Coagulation Disorders; Calciphylaxis; Disease Susceptibility; Humans; Nadroparin; Protein C; P | 1997 |
[Risk patients in dentistry].
Topics: Acenocoumarol; Adult; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation Disorders; Blood Loss | 1999 |
[Changes of the hemostasis system in patients with obturation jaundice caused by choledocholithiasis, and possibilities of their correction with the help of miniinvasive operative interventions].
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Choledocholithiasis; Drug Admi | 2014 |
Rotational thromboelastometry in young, previously healthy patients with SARS-Cov2.
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; COVID-19; Enoxaparin; Heparin; Humans; Pyrazoles | 2020 |
Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy.
Topics: Abortion, Habitual; Adult; Anticoagulants; Blood Coagulation Disorders; Cesarean Section; Enoxaparin | 2020 |
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Blood Coagulation Disorders; Blood Coagulati | 2020 |
Spinal haematoma after removal of a thoracic epidural catheter in a patient with coagulopathy resulting from unexpected vitamin K deficiency.
Topics: Aged; Analgesia, Epidural; Anesthesia, General; Anticoagulants; Blood Coagulation Disorders; Blood C | 2013 |
Medical treatment of osteonecrosis of the knee associated with thrombophilia-hypofibrinolysis.
Topics: Adult; Aged; Blood Coagulation Disorders; Disease Progression; Enoxaparin; Female; Fibrinolysis; Fib | 2014 |
Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Topics: Anticoagulants; Blood Coagulation Disorders; Enoxaparin; Hemorrhage; Heparin; Hospitalization; Human | 2015 |
Epidural analgesia and liver resection: postoperative coagulation disorders and epidural catheter removal.
Topics: Aged; Analgesia, Epidural; Anticoagulants; Blood Coagulation Disorders; Blood Transfusion; Catheteri | 2011 |
[Correction of hemocoagulation disorders in complicated forms of acute cholecystitis].
Topics: Acute Disease; Aged; Anticoagulants; Blood Coagulation Disorders; Cholecystitis; Enoxaparin; Female; | 2002 |
Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Biocompatible Materials; Blood Coagulation; Blood Co | 2004 |
Enoxaparin prevents progression of stages I and II osteonecrosis of the hip.
Topics: Arthroplasty, Replacement, Hip; Blood Coagulation Disorders; Disease Progression; Enoxaparin; Female | 2005 |
Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy.
Topics: Adolescent; Blood Coagulation Disorders; Child; Child, Preschool; Enoxaparin; Female; Humans; Male; | 2007 |
Deep venous thrombosis in a preterm newborn of a mother with activated protein C resistance.
Topics: Adult; Blood Coagulation Disorders; Enoxaparin; Female; Humans; Infant, Newborn; Infant, Premature, | 1998 |
Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19 Drug Treatment; Crit | 2020 |